Teri Jones Heiland
Founder at Immunomic Therapeutics, Inc.
Profile
Teri Jones Heiland is the founder of Capital Genomix, Inc., Immunomic Therapeutics, Inc. She previously worked as a Senior Scientist at Kirkegaard & Perry Laboratories, Inc. She holds a doctorate degree from the University of Missouri, which she received in 1993.
Teri Jones Heiland active positions
| Companies | Position | Start |
|---|---|---|
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Founder | - |
Former positions of Teri Jones Heiland
| Companies | Position | End |
|---|---|---|
Kirkegaard & Perry Laboratories, Inc.
 Kirkegaard & Perry Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Part of LGC Ltd., Kirkegaard & Perry Laboratories, Inc. develops, manufactures, and markets immunochemicals. The company is based in Gaithersburg, MD. Kirkegaard & Perry Laboratories was acquired by SeraCare Life Sciences, Inc., part of LGC Ltd. from November 26, 2018 on August 19, 2013. | Chief Tech/Sci/R&D Officer | - |
Capital Genomix, Inc.
 Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Founder | - |
Training of Teri Jones Heiland
| University of Missouri | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Capital Genomix, Inc.
Capital Genomix, Inc. Medical SpecialtiesHealth Technology Capital Genomix, Inc. develops and markets novel antibody based therapeutics. The firm possesses two genomic and proteomic drug development technology platforms, GeneSystem320 and ImmunoMouse. The company was founded in August 2000 and is headquartered in Gaithersburg, MD. | Health Technology |
Kirkegaard & Perry Laboratories, Inc.
Kirkegaard & Perry Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Part of LGC Ltd., Kirkegaard & Perry Laboratories, Inc. develops, manufactures, and markets immunochemicals. The company is based in Gaithersburg, MD. Kirkegaard & Perry Laboratories was acquired by SeraCare Life Sciences, Inc., part of LGC Ltd. from November 26, 2018 on August 19, 2013. | Process Industries |
- Stock Market
- Insiders
- Teri Jones Heiland
